Literature DB >> 9129057

Wilms' tumor gene expression in human CD34+ hematopoietic progenitors during fetal development and early clonogenic growth.

H D Menssen, H J Renkl, M Entezami, E Thiel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9129057

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  7 in total

Review 1.  Role of the Wilms' tumour transcription factor, Wt1, in blood vessel formation.

Authors:  Holger Scholz; Kay-Dietrich Wagner; Nicole Wagner
Journal:  Pflugers Arch       Date:  2008-12-04       Impact factor: 3.657

2.  The Wilms tumor suppressor WT1 directs stage-specific quiescence and differentiation of human hematopoietic progenitor cells.

Authors:  L W Ellisen; N Carlesso; T Cheng; D T Scadden; D A Haber
Journal:  EMBO J       Date:  2001-04-17       Impact factor: 11.598

3.  Tumor-associated antigens in breast cancer.

Authors:  Carmen Criscitiello
Journal:  Breast Care (Basel)       Date:  2012-08       Impact factor: 2.860

4.  Mesothelium contributes to vascular smooth muscle and mesenchyme during lung development.

Authors:  Jianwen Que; Bettina Wilm; Hiroshi Hasegawa; Fan Wang; David Bader; Brigid L M Hogan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-15       Impact factor: 11.205

Review 5.  Wilms tumor gene (WT1) expression as a panleukemic marker.

Authors:  Hans D Menssen; Jan M Siehl; Eckhard Thiel
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

6.  Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth.

Authors:  Y Oji; H Ogawa; H Tamaki; Y Oka; A Tsuboi; E H Kim; T Soma; T Tatekawa; M Kawakami; M Asada; T Kishimoto; H Sugiyama
Journal:  Jpn J Cancer Res       Date:  1999-02

7.  Wilms' Tumour 1 (WT1) peptide vaccination in patients with acute myeloid leukaemia induces short-lived WT1-specific immune responses.

Authors:  Benjamin Uttenthal; Irma Martinez-Davila; Adam Ivey; Charles Craddock; Frederick Chen; Andras Virchis; Panagiotis Kottaridis; David Grimwade; Asim Khwaja; Hans Stauss; Emma C Morris
Journal:  Br J Haematol       Date:  2013-11-16       Impact factor: 6.998
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.